✨ Your Portfolio is fetched and updated from zerodha.
Small
Market Cap
₹10,507 Cr.
P/E
34.96

Key Ratios

Market cap
Market cap
10,507 Cr
PE
PE
34.96
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
43.66
ROCE (%)
ROCE (%)
57.38
Div Yield (%)
Div Yield (%)
4.85
Sales
Sales
1,272 Cr
OPM (%)
OPM (%)
32.11 %
Debt to Equity
Debt to Equity
-
About
Procter&Gamble Healt is in the Miscellaneous sector with a M.cap of 10507.00 Cr and a … Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Procter & Gamble Health Ltd. Business

Procter & Gamble Health Limited, formerly Merck Limited, is a leading healthcare company in India that expanded its operations through the acquisition of Merck's Consumer Health business in 2018.

Procter&Gamble Healt major competitors are Sanofi India, Strides Pharma Scien, Marksans Pharma, FDC, Natco Pharma, Caplin Point Lab, Jubilant Pharmova.
Market Cap of Procter&Gamble Healt is ₹10,479 Crs.
While the median market cap of its peers are ₹11,786 Crs.

Procter&Gamble Healt seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material